Inflammation and cancer: The oncogene-driven connection

被引:91
作者
Borrello, Maria Grazia [1 ]
Degl'Innocenti, Debora [1 ]
Pierotti, Marco A. [2 ]
机构
[1] IRCCS Ist Nazl Tumori Fdn, Dept Expt Oncol, Operat Unit Mol Mech Canc Growth & Progress, I-20133 Milan, Italy
[2] IRCCS Ist Nazl Tumori Fdn, Sci Directorate, I-20133 Milan, Italy
关键词
oncogenes; inflammation; cancer;
D O I
10.1016/j.canlet.2008.03.060
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Inflammation has long been suspected to contribute to tumor growth. However, the concept that oncogenes. known for decades as responsible for cell neoplastic transformation, build Lip all inflammatory pro-tumorigenic microenvironment is emerging only in the last few years. The well known oncogenes RAS and MYC have been causally linked to tumor angiogenesis through different ways. Moreover, in thyroid tumours, Where many of the genetic tumour-initiating events have been identified. the oncogenes driving tumorigenesis were proved able to induce art inflammatory program. This minireview will focus on growing evidence implicating the role of intrinsic. oncogene-driven pathways leading to pro-tumoral inflammation. (C) 2008 Elsevier Ireland Lid. All rights reserved.
引用
收藏
页码:262 / 270
页数:9
相关论文
共 57 条
[1]   RET and NTRK1 proto-oncogenes in human diseases [J].
Albert, L ;
Carniti, C ;
Miranda, C ;
Roccato, E ;
Pierotti, MA .
JOURNAL OF CELLULAR PHYSIOLOGY, 2003, 195 (02) :168-186
[2]   Oncogenic Ras-induced secretion of IL6 is required for tumorigenesis [J].
Ancrile, Brooke ;
Lim, Kian-Huat ;
Counter, Christopher M. .
GENES & DEVELOPMENT, 2007, 21 (14) :1714-1719
[3]   RET tyrosine kinase signaling in development and cancer [J].
Arighi, E ;
Borrello, MG ;
Sariola, H .
CYTOKINE & GROWTH FACTOR REVIEWS, 2005, 16 (4-5) :441-467
[4]   Deregulated activation of oncoprotein kinase Tpl2/Cot in HTLV-I-transformed T cells [J].
Babu, Geetha ;
Waterfield, Michael ;
Chang, Mikyoung ;
Wu, Xuefeng ;
Sun, Shao-Cong .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (20) :14041-14047
[5]   The significance of cancer cell expression of the chemokine receptor CXCR4 [J].
Balkwill, F .
SEMINARS IN CANCER BIOLOGY, 2004, 14 (03) :171-179
[6]   Inflammation and cancer: back to Virchow? [J].
Balkwill, F ;
Mantovani, A .
LANCET, 2001, 357 (9255) :539-545
[7]   Effects of pharmacologic antagonists of epidermal growth factor receptor, PI3K and MEK signal kinases on NF-κB and AP-1 activation and IL-8 and VEGF expression in human head and neck squamous cell carcinoma lines [J].
Bancroft, CC ;
Chen, Z ;
Yeh, J ;
Sunwoo, JB ;
Yeh, NT ;
Jackson, S ;
Jackson, C ;
Van Waes, C .
INTERNATIONAL JOURNAL OF CANCER, 2002, 99 (04) :538-548
[8]   Induction of a proinflammatory program in normal human thyrocytes by the RET/PTC1 oncogene [J].
Borrello, MG ;
Alberti, L ;
Fischer, A ;
Degl'Innocenti, D ;
Ferrario, C ;
Gariboldi, M ;
Marchesi, F ;
Allavena, P ;
Greco, A ;
Collini, P ;
Pilotti, S ;
Cassinelli, G ;
Bressan, P ;
Fugazzola, L ;
Mantovani, A ;
Pierotti, MA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (41) :14825-14830
[9]  
BOS JL, 1989, CANCER RES, V49, P4682
[10]  
Bruns CJ, 2000, CANCER RES, V60, P2926